News Sentiment

688278 sentiment intelligence

Xiamen Amoytop Biotech Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 5 relevant articles
Exchange SHH China
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 57.53 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Deals and strategy

66/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+3.3% over one week, +3.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Aligos Therapeutics' Shares Rally Following $25M Payment From Xiamen Amoytop Biotech

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Deals and strategy 66/100 classification
One-week reaction 3.3% Price confirming higher
Trend fit Trend inactive 3.1% over four weeks
Fair value -9.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 2
Moomoo 1
The Pharma Letter 1
Barron's 1

Event Lens

What the news is about

Classified themes
Deals and strategy 3
Market update 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5